Risultati della ricerca - Geetha, Duvuru

Raffina i risultati
  1. 1
    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis

    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis di Shah, Shivani, Geetha, Duvuru

    Pubblicazione 2015
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis

    Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis di Kant, Sam, Geetha, Duvuru

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature

    Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literatur... di Lee, Scott M, Geetha, Duvuru

    Pubblicazione 2015
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Keeping Up with the Times: Prognostic Tools in ANCA-Associated Glomerulonephritis

    Keeping Up with the Times: Prognostic Tools in ANCA-Associated Glomerulonephritis di Brix, Silke R., Geetha, Duvuru

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis

    Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis di Kant, Sam, Azar, Antoine, Geetha, Duvuru

    Pubblicazione 2022
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study

    Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study di Manno, Rebecca L., Seo, Philip, Geetha, Duvuru

    Pubblicazione 2015
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model?

    Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model? di Kronbichler, Andreas, Shin, Jae Il, Geetha, Duvuru

    Pubblicazione 2022
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Immune checkpoint inhibitors as potential triggers for ANCA vasculitis

    Immune checkpoint inhibitors as potential triggers for ANCA vasculitis di Aqeel, Faten, Monroy-Trujillo, Jose, Geetha, Duvuru

    Pubblicazione 2022
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis

    Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis di Shah, Shivani, Jaggi, Khushleen, Greenberg, Keiko, Geetha, Duvuru

    Pubblicazione 2017
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis

    Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis di Jin, Qiuyu, Kant, Sam, Alhariri, Jihad, Geetha, Duvuru

    Pubblicazione 2018
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Outcomes of hydralazine induced renal vasculitis

    Outcomes of hydralazine induced renal vasculitis di Timlin, Homa, Liebowitz, Jason E., Jaggi, Khusleen, Geetha, Duvuru

    Pubblicazione 2018
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic

    Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic di Gapud, Eric J., Kronbichler, Andreas, Gauckler, Philipp, Geetha, Duvuru

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

    Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis di Ghosh, Jyotsna, Kant, Sam, Kastner, Isabel Villegas, Geetha, Duvuru

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis

    Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis di Chen, Teresa K., Murakami, Christine, Manno, Rebecca L., Geetha, Duvuru

    Pubblicazione 2014
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis

    Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis di Dein, Eric J, Crespo-Bosque, Monica, Timlin, Homa, Geetha, Duvuru

    Pubblicazione 2018
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists

    Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists di Kant, Sam, Kronbichler, Andreas, Salas, Antonio, Bruchfeld, Annette, Geetha, Duvuru

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy

    Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy di Gapud, Eric J, Manno, Rebecca, Seo, Philip, Hanouneh, Mohamad, Geetha, Duvuru

    Pubblicazione 2018
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors

    Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors di Isaacs, Bradley, Gapud, Eric J., Antiochos, Brendan, Seo, Philip, Geetha, Duvuru

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage

    Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage di Dein, Eric, Manno, Rebecca, Syed, Abrahim, Douglas, Homeyra, Geetha, Duvuru, Timlin, Homa

    Pubblicazione 2018
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis di Kant, Sam, Raman, Gaurav, Damera, Pranav, Antiochos, Brendan, Seo, Philip, Geetha, Duvuru

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: